Abstract
顾云娟,贾伟平.降糖药物与恶性肿瘤关系的研究进展[J].Chinese journal of Epidemiology,2011,32(11):1170-1173
降糖药物与恶性肿瘤关系的研究进展
The relationship of antidiabetic drugs and cancer risk
Received:May 16, 2011  
DOI:
KeyWord: 糖尿病  恶性肿瘤  降糖药物
English Key Word: Diabetes  Neoplasms  Antidiabetic drugs
FundProject:上海市科学计划委员会重大项目(09DZ1950202)
Author NameAffiliationE-mail
GU Yun-juan ############################################################################################################################################################################################################################################################### wpjia@yahoo.com 
Hits: 2352
Download times: 1442
Abstract:
      有研究认为糖尿病与某些肿瘤的发生相关。而长期的糖尿病病程中各种降糖药的使用是否也参与其中,目前还不明确
English Abstract:
      objective To analyze the risk factors related to survival time of advanced non- small cell lung cancer(NSCLC)and to establish a prediction model on survival time.Methods From 2004-2006.1 84 patients with advanced NSCLC were enrolled in the Affiliated Hospital to the Nantong Midical College.Related risk factors were analyzed.using the Buckley-James model.Both actual and predicted survival time were compared by log.rank test.Results Through Buckley-James model analysis,data showed that loS,clinical stage,treatment and pre-treatment hemoglobin were main influencing factors on survival time.Regression equation appeared to be InMONTH= 0.0108 KPS+0.0238 HB+0.4614 IIIb+0.8027Ⅲa+0.3869(radiotherapy+chemotherapy)+0.507 (radiotherapy+operation)+0.6082(chemotherapy+operation)一2.098.There was no statistical difference between the prediction and the actual models of survival time by log-rank test(P----0.575> O.05).Conclusion KPS,clinical stage,treatment and pre.treatment hemoglobin might be associated. Both the prognosis of patients with advanced NSCLC and the prediction model seemed to have practical signiflcances.
View Fulltext   Html FullText     View/Add Comment  Download reader
Close